Pharma times RSS Feed

Clinical study is researching patients with diabetes and advanced chronic kidney disease

Therapy involves patients with paediatric-onset hypophosphatasia – a rare bone disease

Trial will evaluate efficacy of anti-netrin-1 antibody candidate NP137 in combination with Atezo-bev

Treatment involves adult patients with relapsed or refractory diffuse large B-cell lymphoma

Data shows that STC-15 exhibits efficacy as a single agent and in combination with venetoclax

New enteric-coated tablet formulation will now replace the previous prototype capsule

Amber-UI presents a significant opportunity to treat urge and mixed urinary incontinence

Therapy involves renal transplant patients requiring treatment of BK polyomavirus infection

Treatment is a maintenance therapy for certain patients with acute myeloid leukaemia

During the research SonoTran is being evaluated in patients with metastatic colorectal cancer

Therapy involves patients living with relapsed or refractory multiple myeloma

The NICE recommendation followed data from clinical trials and real-world evidence

Therapy is among the first to receive a positive draft recommendation under streamlined pilot process

The new funding package will be used to progress NeoPhore’s expanding pipeline of therapies

Unrelenting pressure caused by strikes, flu and COVID-19 may be keeping NHS in vicious cycle

Therapy is the first oral MET inhibitor treatment option for certain advanced NSCLC adult patients

Biosimilar gains MHRA marketing authorisation for use throughout Britain

Industry-first cancer screening technology boosted by biomedical grant funding

MHRA approval relates to the company’s midlands-based drug development facilities

Major industry names depart leaving UK pricing deal in serious jeopardy